Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies
暂无分享,去创建一个
Heng Li | Yunling Xu | Wei-Chen Chen | Lilly Q Yue | Nelson Lu | Chenguang Wang | Ram Tiwari | Chenguang Wang | R. Tiwari | Heng Li | Nelson Lu | Yunling Xu | Wei-Chen Chen | L. Yue*
[1] D. Rubin. For objective causal inference, design trumps analysis , 2008, 0811.1640.
[2] N. Reid,et al. AN OVERVIEW OF COMPOSITE LIKELIHOOD METHODS , 2011 .
[3] Jeremy A Rassen,et al. Metrics for covariate balance in cohort studies of causal effects , 2014, Statistics in medicine.
[4] Harry Joe,et al. Composite Likelihood Methods , 2012 .
[5] Jerome P. Reiter,et al. A comparison of two methods of estimating propensity scores after multiple imputation , 2016, Statistical methods in medical research.
[6] D. Rubin,et al. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .
[7] Michael Gabay,et al. 21st Century Cures Act , 2017 .
[8] V. P. Godambe. An Optimum Property of Regular Maximum Likelihood Estimation , 1960 .
[9] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[10] Gregory Campbell,et al. Utilizing national and international registries to enhance pre-market medical device regulatory evaluation , 2016, Journal of biopharmaceutical statistics.
[11] J. Lunceford,et al. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study , 2004, Statistics in medicine.
[12] Heng Li,et al. A Note on Good Practice of Objective Propensity Score Design for Premarket Nonrandomized Medical Device Studies with an Example , 2016 .
[13] D. Rubin. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials , 2007, Statistics in medicine.
[14] Elizabeth A Stuart,et al. Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.
[15] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[16] Elizabeth A Stuart,et al. Improving propensity score weighting using machine learning , 2010, Statistics in medicine.
[17] Yunling Xu,et al. Designing Premarket Observational Comparative Studies Using Existing Data as Controls: Challenges and Opportunities , 2014, Journal of biopharmaceutical statistics.
[18] Henry F. Inman,et al. The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities , 1989 .
[19] Margaret Gamalo-Siebers,et al. Propensity‐score‐based priors for Bayesian augmented control design , 2018, Pharmaceutical statistics.
[20] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[21] D. Rubin. Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.
[22] R. Tiwari,et al. Propensity score matched augmented controls in randomized clinical trials: A case study , 2018, Pharmaceutical statistics.
[23] D. Rubin,et al. Estimating and Using Propensity Scores with Partially Missing Data , 2000 .
[24] P. Austin. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.